Skip to main content
OpenTrials

Clinical trial condition

Newly Diagnosed Glioblastoma

Explore clinical trials studying Newly Diagnosed Glioblastoma. Study availability and eligibility vary by location and protocol.

14 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Newly Diagnosed Glioblastoma trial results

Recruiting

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

NCT07326566

Conditions
Astrocytoma, Brain Cancer, Brain Diseases, +19 more
Locations
  • University of Alabama at Birmingham O'Neal Comprehensive Cancer Center Birmingham, Alabama, United States
  • Highlands Oncology Group Springdale, Arkansas, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Yale Cancer Center New Haven, Connecticut, United States
View all 22 locations
View Trial Details
Recruiting

New Adjuvant Vaccine in Glioblastoma, a Phase 1/2a Study

NCT06622434

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Department of Neurology, Hopital de la Salpêtrière Paris, Idf, France
  • Neuro-oncology Department, La Timone Hospital Marseille, Provence-Alpes-Côte d'Azur Region, France
  • Department of Neurology, Hopital Saint louis (APHP) Paris, France
View Trial Details
Completed

A Phase III Trial of With Marizomib in Patients With Newly Diagnosed Glioblastoma

NCT03345095

Conditions
Astrocytoma, Glioblastoma, Glioma, +8 more
Locations
  • Mayo Clinic Scottsdale Scottsdale, Arizona, United States
  • University of California at Irvine Orange, California, United States
  • University of California San Francisco, California, United States
  • John Wayne Cancer Institute Santa Monica, California, United States
View all 82 locations
View Trial Details

Related conditions